Management of Acute Kidney Injury in Coronavirus Disease 2019.
Acute Kidney Injury
/ therapy
Anticoagulants
/ therapeutic use
COVID-19
/ blood
Catheterization, Central Venous
Central Venous Catheters
Citric Acid
/ therapeutic use
Continuous Renal Replacement Therapy
/ methods
Hemodialysis Solutions
/ supply & distribution
Hemoperfusion
/ methods
Heparin
/ therapeutic use
Humans
Hybrid Renal Replacement Therapy
/ methods
Intermittent Renal Replacement Therapy
/ methods
Kidneys, Artificial
/ supply & distribution
Partial Thromboplastin Time
Renal Replacement Therapy
/ instrumentation
SARS-CoV-2
Surge Capacity
Thrombophilia
/ blood
Acute kidney injury
COVID-19
Kidney replacement therapy
Journal
Advances in chronic kidney disease
ISSN: 1548-5609
Titre abrégé: Adv Chronic Kidney Dis
Pays: United States
ID NLM: 101209214
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
27
06
2020
revised:
02
08
2020
accepted:
04
08
2020
entrez:
14
12
2020
pubmed:
15
12
2020
medline:
5
1
2021
Statut:
ppublish
Résumé
Acute kidney injury is a common complication in hospitalized patients with coronavirus disease 2019. Similar to acute kidney injury associated with other conditions such as sepsis and cardiac surgery, morbidity and mortality are much higher in patients with coronavirus disease 2019 who develop acute kidney injury, especially in the intensive care unit. Management of coronavirus disease 2019-associated acute kidney injury with kidney replacement therapy should follow existing recommendations regarding modality, dose, and timing of initiation. However, patients with coronavirus disease 2019 are very hypercoagulable, and close vigilance to anticoagulation strategies is necessary to prevent circuit clotting. During situations of acute surge, where demand for kidney replacement therapy outweighs supplies, conservative measures have to be implemented to safely delay kidney replacement therapy. A collaborative effort and careful planning is needed to conserve dialysis supplies, to ensure that treatment can be safely delivered to every patient who will benefit for kidney replacement therapy.
Identifiants
pubmed: 33308502
pii: S1548-5595(20)30118-X
doi: 10.1053/j.ackd.2020.08.002
pmc: PMC7409928
pii:
doi:
Substances chimiques
Anticoagulants
0
Hemodialysis Solutions
0
Citric Acid
2968PHW8QP
Heparin
9005-49-6
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
377-382Informations de copyright
Copyright © 2020 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
Références
Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1248-1257
pubmed: 30936153
Perit Dial Int. 2014 Jul-Aug;34(5):544-9
pubmed: 25074997
Semin Dial. 2009 Mar-Apr;22(2):133-6
pubmed: 19426415
Acad Emerg Med. 2020 Jun;27(6):475-486
pubmed: 32149451
Clin J Am Soc Nephrol. 2012 Jun;7(6):887-94
pubmed: 22461532
PLoS One. 2017 Oct 30;12(10):e0187015
pubmed: 29084247
Clin J Am Soc Nephrol. 2012 Aug;7(8):1328-36
pubmed: 22498496
N Engl J Med. 2018 Oct 11;379(15):1431-1442
pubmed: 30304656
Intensive Care Med. 2020 Jun;46(6):1089-1098
pubmed: 32367170
Perit Dial Int. 1998 Sep-Oct;18(5):536-8
pubmed: 9848637
Am J Kidney Dis. 2013 May;61(5):649-72
pubmed: 23499048
P T. 2016 Jan;41(1):43-50
pubmed: 26765867
Crit Care. 2013 Sep 20;17(5):R207
pubmed: 24053972
Kidney360. 2020 Apr 24;1(5):410-415
pubmed: 35369379
N Engl J Med. 2018 Mar 1;378(9):819-828
pubmed: 29485926
Lancet. 2020 May 9;395(10235):1506-1515
pubmed: 32334654
Clin J Am Soc Nephrol. 2020 May 7;15(5):720-722
pubmed: 32245780
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
N Engl J Med. 2008 Jul 3;359(1):7-20
pubmed: 18492867
Semin Nephrol. 2017 Jan;37(1):103-112
pubmed: 28153190
Hemodial Int. 2018 Jan;22(1):50-55
pubmed: 28295984
Kidney360. 2020 May 13;1(7):614-622
pubmed: 35372932
Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2173-88
pubmed: 24993448
Kidney Med. 2020 Apr 23;2(4):377-380
pubmed: 32337505
JAMA. 2018 Oct 9;320(14):1455-1463
pubmed: 30304428
N Engl J Med. 2016 Jul 14;375(2):122-33
pubmed: 27181456
Ann Intensive Care. 2019 Jul 24;9(1):85
pubmed: 31342205
J Am Soc Nephrol. 2020 Jul;31(7):1371-1379
pubmed: 32499395
Adv Chronic Kidney Dis. 2016 May;23(3):195-202
pubmed: 27113696
Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1912-1914
pubmed: 30401735
JAMA. 2015 Oct 27;314(16):1701-10
pubmed: 26444692
Kidney Int. 2020 Jul;98(1):209-218
pubmed: 32416116
N Engl J Med. 2018 Mar 1;378(9):829-839
pubmed: 29485925
Clin J Am Soc Nephrol. 2020 Nov 6;15(11):1660-1662
pubmed: 32404338
Eur Heart J Suppl. 2019 Feb;21(Suppl A):A28-A33
pubmed: 30837802
Am J Kidney Dis. 2020 Sep;76(3):392-400
pubmed: 32505811
Lancet. 2018 Jul 7;392(10141):31-40
pubmed: 29910040
Am J Kidney Dis. 2012 Aug;60(2):272-9
pubmed: 22497790